Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Merck
Covington
US Army
McKesson
Farmers Insurance
Chinese Patent Office
Citi

Generated: June 20, 2018

DrugPatentWatch Database Preview

AMINOSYN II 10% W/ ELECTROLYTES Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Aminosyn Ii 10% W/ Electrolytes, and when can generic versions of Aminosyn Ii 10% W/ Electrolytes launch?

Aminosyn Ii 10% W/ Electrolytes is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in AMINOSYN II 10% W/ ELECTROLYTES is amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride profile page.

US Patents and Regulatory Information for AMINOSYN II 10% W/ ELECTROLYTES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc AMINOSYN II 10% W/ ELECTROLYTES amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 019437-004 Apr 3, 1986 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Accenture
US Department of Justice
Argus Health
AstraZeneca
Federal Trade Commission
Dow
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.